Additionally, it addresses the FDA’s communications With all the applicant, the retention of data that aid the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant might transfer ownership of an SE report back to a new applicant and electronic submission from the SE report and amendmen